Sanitas AB

Sanitas AB, a pharmaceutical preparation manufacturing company headquartered in LT, has reported its carbon emissions for 2024 and 2023. In 2024, the company's total emissions were approximately 11.5 million kg CO2e. This comprised of approximately 119,000 kg CO2e in Scope 1 emissions, primarily from stationary combustion (about 82,000 kg CO2e), and approximately 26,000 kg CO2e in Scope 2 emissions, mainly from purchased heat (about 25,000 kg CO2e). Scope 3 emissions for 2024 were approximately 10.9 million kg CO2e, with purchased goods and services contributing the largest share at about 10.3 million kg CO2e.

For the preceding year, 2023, Sanitas AB reported total emissions of approximately 11.2 million kg CO2e. Scope 1 emissions were about 138,000 kg CO2e, with stationary combustion accounting for approximately 93,000 kg CO2e. Scope 2 emissions were around 40,000 kg CO2e, with purchased heat being the dominant factor at approximately 39,000 kg CO2e. The company's Scope 3 emissions in 2023 amounted to approximately 10.8 million kg CO2e, with purchased goods and services representing approximately 10.5 million kg CO2e.

Sanitas AB is a signatory to the Climate Pledge, having signed in February 2023. This commitment is cascaded from its ultimate parent organization, The British United Provident Association Limited, for its SBTi and CDP initiatives. The company’s emission data is not cascaded from a higher entity. While specific reduction targets are not detailed, the Climate Pledge signifies a commitment to net-zero carbon emissions across their businesses by 2040.